Regencell Bioscience Holdings Ltd is a biotechnology company focused on developing innovative therapies for neurological disorders
The company is actively engaged in the research and commercialization of novel treatments aimed at addressing conditions such as attention deficit hyperactivity disorder (ADHD) and other cognitive impairments. Through its cutting-edge approaches and commitment to scientific advancement, Regencell strives to enhance the quality of life for individuals affected by these challenges, with a strong emphasis on evidence-based solutions and therapeutic efficacy.
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
